Sisomicin: Biochemical and microbiological profile M. ScheerM. J. WeinsteinJ. A. Waitz I. Biochemical And In Vitro Studies Pages: S241 - S242
Comparison of the antimicrobial effects of four aminoglycoside antibiotics H. Grimm I. Biochemical And In Vitro Studies Pages: S242 - S243
Sisomicin: Antibacterial activity in vitro S. Ortel I. Biochemical And In Vitro Studies Pages: S243 - S244
Effect of oxygen concentration and pH level on the antistaphylococcal activity of sisomicin and gentamicin A. BoisivonC. H. RufJ. F. Acar I. Biochemical And In Vitro Studies Pages: S244 - S245
Comparative in vitro activity of sisomicin and its interactions with beta-lactam antibiotics H. GayaE. M. BrownS. E. M. Cox I. Biochemical And In Vitro Studies Pages: S246 - S246
Sensitivity of Enterobacteriaceae and Pseudomonas aeruginosa to sisomicin Ch. KrasemannE. Prior I. Biochemical And In Vitro Studies Pages: S247 - S247
In vitro activity of new aminoglycoside antibiotics alone and with beta-lactam antibiotics H. H. Schassan I. Biochemical And In Vitro Studies Pages: S248 - S249
Synergistic effects of azlocillin and mezlocillin with the aminoglycosides in nosocomial infections F. Daschner I. Biochemical And In Vitro Studies Pages: S250 - S251
Toxicological studies with sisomicin K. HoffmannG. Luckhaus II. Toxicology And In Vivo Studies Pages: S252 - S253
Experimental studies on sisomicin ototoxicity in guinea pigs J. WersällM. AnnikoB. Björkroth II. Toxicology And In Vivo Studies Pages: S254 - S254
Comparative ototoxicity of gentamicin and sisomicin in the cat M. IgarashiM. Takahashi II. Toxicology And In Vivo Studies Pages: S255 - S256
Comparison of effects of gentamicin and sisomicin on kidney function in rats P. J. S. ChiuG. H. MillerJ. F. Long II. Toxicology And In Vivo Studies Pages: S256 - S257
The effect of aminoglycosides on proximal tubular membranes of human kidneys A. W. MondorfJ. BreierW. Schoeppe II. Toxicology And In Vivo Studies Pages: S257 - S258
Aminoglycoside antibiotics and experimental pyelonephritis W. Ritzerfeld OriginalPaper Pages: S258 - S259
Activity of sisomicin in experimental infections J. A. WaitzG. H. Miller II. Toxicology And In Vivo Studies Pages: S259 - S262
Sisomicin versus gentamicin: A comparison of serum levels and recovery in urine P. NaumannH. Rosin III. Pharmacokinetics Pages: S263 - S263
Pharmacokinetic behavior of sisomicin after single injection J. C. PechèreR. Dugal III. Pharmacokinetics Pages: S264 - S265
Pharmacokinetics of sisomicin in normal subjects and patients with renal failure G. HumbertJ. P. FillastreG. Oksenhendler III. Pharmacokinetics Pages: S265 - S266
A comparison of sisomicin and gentamicin pharmacokinetics V. C. Simon IV. Concentrations In Body Fluids And Human Tissue Homogenates/Clinical Studies In Urinary Tract Infections Pages: S268 - S268
Concentration of sisomicin in body fluids and human tissue homogenates W. IrmerM. ScheerJ. Winter IV. Concentrations In Body Fluids And Human Tissue Homogenates/Clinical Studies In Urinary Tract Infections Pages: S268 - S269
Sisomicin concentrations in serum and bronchial secretions after endotracheal administration J. P. ThijsE. MouawadJ. Klastersky IV. Concentrations In Body Fluids And Human Tissue Homogenates/Clinical Studies In Urinary Tract Infections Pages: S269 - S270
Sisomicin concentrations in serum and gynecological tissue homogenates H. LohmeyerJ. WiedH. Hölting OriginalPaper Pages: S271 - S271
Sisomicin treatment of complicated urinary tract infections P. O. MadsenT. B. KjaerP. G. Welling OriginalPaper Pages: S272 - S272
Sisomicin therapy of complicated urinary tract infections V. BonominiP. Scolari IV. Concentrations In Body Fluids And Human Tissue Homogenates/Clinical Studies In Urinary Tract Infections Pages: S273 - S273
Sisomicin in the treatment of urinary tract infections R. Gomez-LusF. Romero AguirreC. Garcia Garcia IV. Concentrations In Body Fluids And Human Tissue Homogenates/Clinical Studies In Urinary Tract Infections Pages: S274 - S274
Sisomicin: Pharmacokinetics and therapy in patients with normal and reduced renal function K. NaberS. RothH. Lange OriginalPaper Pages: S275 - S275
Pharmacokinetic studies with sisomicin in obstetrics D. von KohyletzkiM. SasM. Scheer V. Pediatric And Special Clinical Studies Pages: S276 - S276
Pharmacokinetics of sisomicin in pediatrics with particular consideration of the newborn infant L. WeingärtnerU. SitkaR. Patsch OriginalPaper Pages: S277 - S277
Pharmacokinetics of sisomicin in pediatric patients F. BachmannS. KleinerP. Farner V. Pediatric And Special Clinical Studies Pages: S278 - S278
Sisomicin treatment of serious neonatal infections P. HenrikssonN. W. SvenningsenK. Haeger V. Pediatric And Special Clinical Studies Pages: S278 - S279
Sisomicin therapy in newborn infants with increased infection risk K. Rosanelli V. Pediatric And Special Clinical Studies Pages: S279 - S280
Clinical, bacteriological and pharmacokinetic studies of sisomicin in the newborn infant M. SorinF. de MerleireP. Berche V. Pediatric And Special Clinical Studies Pages: S280 - S281
Experience with sisomicin in the treatment of pediatric urinary tract infections G. WeißenbacherE. Balzar V. Pediatric And Special Clinical Studies Pages: S281 - S281
Clinical and bacteriological studies on the effects of sisomicin in serious bronchopulmonary infections H. DuwoosC. AbderhaldenP. Carpentier V. Pediatric And Special Clinical Studies Pages: S282 - S282
Sisomicin treatment of bronchopulmonary infections G. BureauM. C. LevelJ. M. Dubois de Montreynaud V. Pediatric And Special Clinical Studies Pages: S282 - S283
A preliminary report on serum concentrations of sisomicin following aerosol inhalation and intravenous injection P. -E. HellströmG. GruenwaldtM. Scheer V. Pediatric And Special Clinical Studies Pages: S283 - S284
Clinical and bacteriological evaluation of sisomicin therapy in serious infections P. GötzkyS. HeinrichH. -J. Decius V. Pediatric And Special Clinical Studies Pages: S284 - S285
Endotracheally administered sisomicin in severe gram-negative bronchopulmonary infections: A preliminary evaluation J. KlasterskyF. Meunier-CarpentierJ. P. Thijs V. Pediatric And Special Clinical Studies Pages: S285 - S286
Therapy of serious gram-negative infections with a new aminoglycoside H. C. NeuM. F. Parry VI. Clinical Experience Pages: S287 - S288
Pharmacokinetics and efficacy of sisomicin in patients with urinary tract infections L. WeissbachJ. GillissenH. Lode VI. Clinical Experience Pages: S288 - S289
Sisomicin — efficacy and tolerance of various dosages in urinary tract infections I. ThompsonG. Ross VI. Clinical Experience Pages: S289 - S290
Clinical experience with new aminoglycoside antibiotics H. LodeK. GrunertB. Kemmerich VI. Clinical Experience Pages: S290 - S292
Sisomicin alone and in combination for infections in cancer patients G. P. BodeyF. CabanillasK. McCredie VI. Clinical Experience Pages: S292 - S294
Clinical experience with sisomicin in urinary tract infections with particular attention to pharmacokinetics R. NeddenT. FuchsH. -U. Klinkenberg VI. Clinical Experience Pages: S294 - S295
Sisomicin in the treatment of bacterial urinary tract infections J. J. WyndaeleW. de SyR. Desmet VI. Clinical Experience Pages: S295 - S295
Treatment of gynecological infections with sisomicin A. MoriciG. PietrojustiG. Pavone VI. Clinical Experience Pages: S296 - S297